Xeris Pharmaceuticals | XERS - Przychody Ze Sprzedaży





Obroty Zmiana Data
Celltrion KRW 1.24T 90B 2026-06
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 27.58B 730M 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
Kangmei Pharma CNY 1.19B 106M 2026-06
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 59.79M 3.74M 2026-03
Pacira USD 192.4M 15.4M 2026-06
Perrigo USD 1.02B 51M 2026-06
Pharma Mar EUR 50M 7.1M 2026-06
Qiagen NV USD 463.12M 43.9M 2026-06
Sartorius EUR 911.8M 12.7M 2026-06
Sino Biopharmaceutical CNY 19.44B 5.18B 2026-06
Supernus Pharmaceuticals USD 219.1M 11.39M 2026-06
Tilray USD 217.51M 74.75M 2025-12
Zealand Pharma A/S 34M 34.92M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 1.83B 887.63M 2026-06